カテゴリー： 世界, 部品/材料, LP Information

世界のメチマゾールAPI市場予測 2023年-2029年

【英語タイトル】Global Methimazole API Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC03016）・商品コード：LP23DC03016
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のメチマゾールAPI市場」は、過去の販売実績から2022年の世界のメチマゾールAPIの総販売量を検討し、2023年から2029年の予測されるメチマゾールAPIの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のメチマゾールAPIの市場規模を掲載し、XXX百万米ドル規模の世界のメチマゾールAPI市場の詳細な分析を提供します。本インサイトレポートは、世界のメチマゾールAPI業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のメチマゾールAPI市場における各社の独自のポジションをより深く理解するために、メチマゾールAPI製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のメチマゾールAPI市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。メチマゾールAPIの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。メチマゾールAPIの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。メチマゾールAPIのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

メチマゾールAPIの世界主要メーカーとしては、CU CHEMIE UETIKON GMBH、 MACLEODS PHARMACEUTICALS LTD、 MAITHRI DRUGS PRIVATE LTD、 Beijing Taiyang Pharmaceutical Co., Ltd.、 Beijing Beiwei Pharmaceutical Co., Ltd.、 Beijing Tongjida Pharmaceutical Co., Ltd.、 Guizhou Shengjitang Pharmaceutical Co., Ltd.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のメチマゾールAPI市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではメチマゾールAPI市場をセグメンテーションし、種類別 (純度≧99%、純度<99%)、用途別 (錠剤、クリーム、腸溶錠)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度≧99%、純度<99%

・用途別区分：錠剤、クリーム、腸溶錠

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のメチマゾールAPI市場の10年間の市場状況・展望は？
・世界および地域別に見たメチマゾールAPI市場成長の要因は何か？
・メチマゾールAPIの市場機会はエンドマーケットの規模によってどのように変化するのか？
・メチマゾールAPIのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：メチマゾールAPIの年間販売量2018-2029、地域別現状・将来分析
・メチマゾールAPIの種類別セグメント：純度≧99%、純度<99%
・メチマゾールAPIの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・メチマゾールAPIの用途別セグメント：錠剤、クリーム、腸溶錠
・メチマゾールAPIの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のメチマゾールAPI市場
・企業別のグローバルメチマゾールAPI市場データ：2018-2023年の年間販売量、市場シェア
・企業別のメチマゾールAPIの年間売上：2018-2023年の売上、市場シェア
・企業別のメチマゾールAPI販売価格
・主要企業のメチマゾールAPI生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

メチマゾールAPIの地域別レビュー
・地域別のメチマゾールAPI市場規模2018-2023：年間販売量、売上
・主要国別のメチマゾールAPI市場規模2018-2023：年間販売量、売上
・南北アメリカのメチマゾールAPI販売の成長
・アジア太平洋のメチマゾールAPI販売の成長
・ヨーロッパのメチマゾールAPI販売の成長
・中東・アフリカのメチマゾールAPI販売の成長

南北アメリカ市場
・南北アメリカの国別のメチマゾールAPI販売量、売上（2018-2023）
・南北アメリカのメチマゾールAPIの種類別販売量
・南北アメリカのメチマゾールAPIの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のメチマゾールAPI販売量、売上（2018-2023）
・アジア太平洋のメチマゾールAPIの種類別販売量
・アジア太平洋のメチマゾールAPIの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のメチマゾールAPI販売量、売上（2018-2023）
・ヨーロッパのメチマゾールAPIの種類別販売量
・ヨーロッパのメチマゾールAPIの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のメチマゾールAPI販売量、売上（2018-2023）
・中東・アフリカのメチマゾールAPIの種類別販売量
・中東・アフリカのメチマゾールAPIの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・メチマゾールAPIの製造コスト構造分析
・メチマゾールAPIの製造プロセス分析
・メチマゾールAPIの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・メチマゾールAPIの主要なグローバル販売業者
・メチマゾールAPIの主要なグローバル顧客

地域別のメチマゾールAPI市場予測レビュー
・地域別のメチマゾールAPI市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・メチマゾールAPIの種類別市場規模予測
・メチマゾールAPIの用途別市場規模予測

主要企業分析
CU CHEMIE UETIKON GMBH、 MACLEODS PHARMACEUTICALS LTD、 MAITHRI DRUGS PRIVATE LTD、 Beijing Taiyang Pharmaceutical Co., Ltd.、 Beijing Beiwei Pharmaceutical Co., Ltd.、 Beijing Tongjida Pharmaceutical Co., Ltd.、 Guizhou Shengjitang Pharmaceutical Co., Ltd.
・企業情報
・メチマゾールAPI製品
・メチマゾールAPI販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Methimazole API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Methimazole API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Methimazole API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Methimazole API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Methimazole API players cover CU CHEMIE UETIKON GMBH, MACLEODS PHARMACEUTICALS LTD, MAITHRI DRUGS PRIVATE LTD, Beijing Taiyang Pharmaceutical Co., Ltd., Beijing Beiwei Pharmaceutical Co., Ltd., Beijing Tongjida Pharmaceutical Co., Ltd. and Guizhou Shengjitang Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Methimazole API Industry Forecast” looks at past sales and reviews total world Methimazole API sales in 2022, providing a comprehensive analysis by region and market sector of projected Methimazole API sales for 2023 through 2029. With Methimazole API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Methimazole API industry.
This Insight Report provides a comprehensive analysis of the global Methimazole API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Methimazole API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Methimazole API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Methimazole API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Methimazole API.
This report presents a comprehensive overview, market shares, and growth opportunities of Methimazole API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity≥99%
Purity<99% Segmentation by application Tablets Cream Enteric-coated Tablets This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. CU CHEMIE UETIKON GMBH MACLEODS PHARMACEUTICALS LTD MAITHRI DRUGS PRIVATE LTD Beijing Taiyang Pharmaceutical Co., Ltd. Beijing Beiwei Pharmaceutical Co., Ltd. Beijing Tongjida Pharmaceutical Co., Ltd. Guizhou Shengjitang Pharmaceutical Co., Ltd. Key Questions Addressed in this Report What is the 10-year outlook for the global Methimazole API market? What factors are driving Methimazole API market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Methimazole API market opportunities vary by end market size? How does Methimazole API break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Methimazole API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Methimazole API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Methimazole API by Country/Region, 2018, 2022 & 2029
2.2 Methimazole API Segment by Type
2.2.1 Purity≥99%
2.2.2 Purity<99% 2.3 Methimazole API Sales by Type 2.3.1 Global Methimazole API Sales Market Share by Type (2018-2023) 2.3.2 Global Methimazole API Revenue and Market Share by Type (2018-2023) 2.3.3 Global Methimazole API Sale Price by Type (2018-2023) 2.4 Methimazole API Segment by Application 2.4.1 Tablets 2.4.2 Cream 2.4.3 Enteric-coated Tablets 2.5 Methimazole API Sales by Application 2.5.1 Global Methimazole API Sale Market Share by Application (2018-2023) 2.5.2 Global Methimazole API Revenue and Market Share by Application (2018-2023) 2.5.3 Global Methimazole API Sale Price by Application (2018-2023) 3 Global Methimazole API by Company 3.1 Global Methimazole API Breakdown Data by Company 3.1.1 Global Methimazole API Annual Sales by Company (2018-2023) 3.1.2 Global Methimazole API Sales Market Share by Company (2018-2023) 3.2 Global Methimazole API Annual Revenue by Company (2018-2023) 3.2.1 Global Methimazole API Revenue by Company (2018-2023) 3.2.2 Global Methimazole API Revenue Market Share by Company (2018-2023) 3.3 Global Methimazole API Sale Price by Company 3.4 Key Manufacturers Methimazole API Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Methimazole API Product Location Distribution 3.4.2 Players Methimazole API Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Methimazole API by Geographic Region 4.1 World Historic Methimazole API Market Size by Geographic Region (2018-2023) 4.1.1 Global Methimazole API Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Methimazole API Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Methimazole API Market Size by Country/Region (2018-2023) 4.2.1 Global Methimazole API Annual Sales by Country/Region (2018-2023) 4.2.2 Global Methimazole API Annual Revenue by Country/Region (2018-2023) 4.3 Americas Methimazole API Sales Growth 4.4 APAC Methimazole API Sales Growth 4.5 Europe Methimazole API Sales Growth 4.6 Middle East & Africa Methimazole API Sales Growth 5 Americas 5.1 Americas Methimazole API Sales by Country 5.1.1 Americas Methimazole API Sales by Country (2018-2023) 5.1.2 Americas Methimazole API Revenue by Country (2018-2023) 5.2 Americas Methimazole API Sales by Type 5.3 Americas Methimazole API Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Methimazole API Sales by Region 6.1.1 APAC Methimazole API Sales by Region (2018-2023) 6.1.2 APAC Methimazole API Revenue by Region (2018-2023) 6.2 APAC Methimazole API Sales by Type 6.3 APAC Methimazole API Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Methimazole API by Country 7.1.1 Europe Methimazole API Sales by Country (2018-2023) 7.1.2 Europe Methimazole API Revenue by Country (2018-2023) 7.2 Europe Methimazole API Sales by Type 7.3 Europe Methimazole API Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Methimazole API by Country 8.1.1 Middle East & Africa Methimazole API Sales by Country (2018-2023) 8.1.2 Middle East & Africa Methimazole API Revenue by Country (2018-2023) 8.2 Middle East & Africa Methimazole API Sales by Type 8.3 Middle East & Africa Methimazole API Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Methimazole API 10.3 Manufacturing Process Analysis of Methimazole API 10.4 Industry Chain Structure of Methimazole API 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Methimazole API Distributors 11.3 Methimazole API Customer 12 World Forecast Review for Methimazole API by Geographic Region 12.1 Global Methimazole API Market Size Forecast by Region 12.1.1 Global Methimazole API Forecast by Region (2024-2029) 12.1.2 Global Methimazole API Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Methimazole API Forecast by Type 12.7 Global Methimazole API Forecast by Application 13 Key Players Analysis 13.1 CU CHEMIE UETIKON GMBH 13.1.1 CU CHEMIE UETIKON GMBH Company Information 13.1.2 CU CHEMIE UETIKON GMBH Methimazole API Product Portfolios and Specifications 13.1.3 CU CHEMIE UETIKON GMBH Methimazole API Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 CU CHEMIE UETIKON GMBH Main Business Overview 13.1.5 CU CHEMIE UETIKON GMBH Latest Developments 13.2 MACLEODS PHARMACEUTICALS LTD 13.2.1 MACLEODS PHARMACEUTICALS LTD Company Information 13.2.2 MACLEODS PHARMACEUTICALS LTD Methimazole API Product Portfolios and Specifications 13.2.3 MACLEODS PHARMACEUTICALS LTD Methimazole API Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 MACLEODS PHARMACEUTICALS LTD Main Business Overview 13.2.5 MACLEODS PHARMACEUTICALS LTD Latest Developments 13.3 MAITHRI DRUGS PRIVATE LTD 13.3.1 MAITHRI DRUGS PRIVATE LTD Company Information 13.3.2 MAITHRI DRUGS PRIVATE LTD Methimazole API Product Portfolios and Specifications 13.3.3 MAITHRI DRUGS PRIVATE LTD Methimazole API Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 MAITHRI DRUGS PRIVATE LTD Main Business Overview 13.3.5 MAITHRI DRUGS PRIVATE LTD Latest Developments 13.4 Beijing Taiyang Pharmaceutical Co., Ltd. 13.4.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information 13.4.2 Beijing Taiyang Pharmaceutical Co., Ltd. Methimazole API Product Portfolios and Specifications 13.4.3 Beijing Taiyang Pharmaceutical Co., Ltd. Methimazole API Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Beijing Taiyang Pharmaceutical Co., Ltd. Main Business Overview 13.4.5 Beijing Taiyang Pharmaceutical Co., Ltd. Latest Developments 13.5 Beijing Beiwei Pharmaceutical Co., Ltd. 13.5.1 Beijing Beiwei Pharmaceutical Co., Ltd. Company Information 13.5.2 Beijing Beiwei Pharmaceutical Co., Ltd. Methimazole API Product Portfolios and Specifications 13.5.3 Beijing Beiwei Pharmaceutical Co., Ltd. Methimazole API Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Beijing Beiwei Pharmaceutical Co., Ltd. Main Business Overview 13.5.5 Beijing Beiwei Pharmaceutical Co., Ltd. Latest Developments 13.6 Beijing Tongjida Pharmaceutical Co., Ltd. 13.6.1 Beijing Tongjida Pharmaceutical Co., Ltd. Company Information 13.6.2 Beijing Tongjida Pharmaceutical Co., Ltd. Methimazole API Product Portfolios and Specifications 13.6.3 Beijing Tongjida Pharmaceutical Co., Ltd. Methimazole API Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Beijing Tongjida Pharmaceutical Co., Ltd. Main Business Overview 13.6.5 Beijing Tongjida Pharmaceutical Co., Ltd. Latest Developments 13.7 Guizhou Shengjitang Pharmaceutical Co., Ltd. 13.7.1 Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information 13.7.2 Guizhou Shengjitang Pharmaceutical Co., Ltd. Methimazole API Product Portfolios and Specifications 13.7.3 Guizhou Shengjitang Pharmaceutical Co., Ltd. Methimazole API Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Guizhou Shengjitang Pharmaceutical Co., Ltd. Main Business Overview 13.7.5 Guizhou Shengjitang Pharmaceutical Co., Ltd. Latest Developments 14 Research Findings and Conclusion

List of Tables
Table 1. Methimazole API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Methimazole API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity≥99%
Table 4. Major Players of Purity<99%
Table 5. Global Methimazole API Sales by Type (2018-2023) & (Tons)
Table 6. Global Methimazole API Sales Market Share by Type (2018-2023)
Table 7. Global Methimazole API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Methimazole API Revenue Market Share by Type (2018-2023)
Table 9. Global Methimazole API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Methimazole API Sales by Application (2018-2023) & (Tons)
Table 11. Global Methimazole API Sales Market Share by Application (2018-2023)
Table 12. Global Methimazole API Revenue by Application (2018-2023)
Table 13. Global Methimazole API Revenue Market Share by Application (2018-2023)
Table 14. Global Methimazole API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Methimazole API Sales by Company (2018-2023) & (Tons)
Table 16. Global Methimazole API Sales Market Share by Company (2018-2023)
Table 17. Global Methimazole API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Methimazole API Revenue Market Share by Company (2018-2023)
Table 19. Global Methimazole API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Methimazole API Producing Area Distribution and Sales Area
Table 21. Players Methimazole API Products Offered
Table 22. Methimazole API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Methimazole API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Methimazole API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Methimazole API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Methimazole API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Methimazole API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Methimazole API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Methimazole API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Methimazole API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Methimazole API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Methimazole API Sales Market Share by Country (2018-2023)
Table 35. Americas Methimazole API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Methimazole API Revenue Market Share by Country (2018-2023)
Table 37. Americas Methimazole API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Methimazole API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Methimazole API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Methimazole API Sales Market Share by Region (2018-2023)
Table 41. APAC Methimazole API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Methimazole API Revenue Market Share by Region (2018-2023)
Table 43. APAC Methimazole API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Methimazole API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Methimazole API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Methimazole API Sales Market Share by Country (2018-2023)
Table 47. Europe Methimazole API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Methimazole API Revenue Market Share by Country (2018-2023)
Table 49. Europe Methimazole API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Methimazole API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Methimazole API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Methimazole API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Methimazole API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Methimazole API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Methimazole API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Methimazole API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Methimazole API
Table 58. Key Market Challenges & Risks of Methimazole API
Table 59. Key Industry Trends of Methimazole API
Table 60. Methimazole API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Methimazole API Distributors List
Table 63. Methimazole API Customer List
Table 64. Global Methimazole API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Methimazole API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Methimazole API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Methimazole API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Methimazole API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Methimazole API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Methimazole API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Methimazole API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Methimazole API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Methimazole API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Methimazole API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Methimazole API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Methimazole API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Methimazole API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. CU CHEMIE UETIKON GMBH Basic Information, Methimazole API Manufacturing Base, Sales Area and Its Competitors
Table 79. CU CHEMIE UETIKON GMBH Methimazole API Product Portfolios and Specifications
Table 80. CU CHEMIE UETIKON GMBH Methimazole API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. CU CHEMIE UETIKON GMBH Main Business
Table 82. CU CHEMIE UETIKON GMBH Latest Developments
Table 83. MACLEODS PHARMACEUTICALS LTD Basic Information, Methimazole API Manufacturing Base, Sales Area and Its Competitors
Table 84. MACLEODS PHARMACEUTICALS LTD Methimazole API Product Portfolios and Specifications
Table 85. MACLEODS PHARMACEUTICALS LTD Methimazole API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. MACLEODS PHARMACEUTICALS LTD Main Business
Table 87. MACLEODS PHARMACEUTICALS LTD Latest Developments
Table 88. MAITHRI DRUGS PRIVATE LTD Basic Information, Methimazole API Manufacturing Base, Sales Area and Its Competitors
Table 89. MAITHRI DRUGS PRIVATE LTD Methimazole API Product Portfolios and Specifications
Table 90. MAITHRI DRUGS PRIVATE LTD Methimazole API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. MAITHRI DRUGS PRIVATE LTD Main Business
Table 92. MAITHRI DRUGS PRIVATE LTD Latest Developments
Table 93. Beijing Taiyang Pharmaceutical Co., Ltd. Basic Information, Methimazole API Manufacturing Base, Sales Area and Its Competitors
Table 94. Beijing Taiyang Pharmaceutical Co., Ltd. Methimazole API Product Portfolios and Specifications
Table 95. Beijing Taiyang Pharmaceutical Co., Ltd. Methimazole API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Beijing Taiyang Pharmaceutical Co., Ltd. Main Business
Table 97. Beijing Taiyang Pharmaceutical Co., Ltd. Latest Developments
Table 98. Beijing Beiwei Pharmaceutical Co., Ltd. Basic Information, Methimazole API Manufacturing Base, Sales Area and Its Competitors
Table 99. Beijing Beiwei Pharmaceutical Co., Ltd. Methimazole API Product Portfolios and Specifications
Table 100. Beijing Beiwei Pharmaceutical Co., Ltd. Methimazole API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Beijing Beiwei Pharmaceutical Co., Ltd. Main Business
Table 102. Beijing Beiwei Pharmaceutical Co., Ltd. Latest Developments
Table 103. Beijing Tongjida Pharmaceutical Co., Ltd. Basic Information, Methimazole API Manufacturing Base, Sales Area and Its Competitors
Table 104. Beijing Tongjida Pharmaceutical Co., Ltd. Methimazole API Product Portfolios and Specifications
Table 105. Beijing Tongjida Pharmaceutical Co., Ltd. Methimazole API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Beijing Tongjida Pharmaceutical Co., Ltd. Main Business
Table 107. Beijing Tongjida Pharmaceutical Co., Ltd. Latest Developments
Table 108. Guizhou Shengjitang Pharmaceutical Co., Ltd. Basic Information, Methimazole API Manufacturing Base, Sales Area and Its Competitors
Table 109. Guizhou Shengjitang Pharmaceutical Co., Ltd. Methimazole API Product Portfolios and Specifications
Table 110. Guizhou Shengjitang Pharmaceutical Co., Ltd. Methimazole API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Guizhou Shengjitang Pharmaceutical Co., Ltd. Main Business
Table 112. Guizhou Shengjitang Pharmaceutical Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Methimazole API
Figure 2. Methimazole API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Methimazole API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Methimazole API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Methimazole API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity≥99%
Figure 10. Product Picture of Purity<99%
Figure 11. Global Methimazole API Sales Market Share by Type in 2022
Figure 12. Global Methimazole API Revenue Market Share by Type (2018-2023)
Figure 13. Methimazole API Consumed in Tablets
Figure 14. Global Methimazole API Market: Tablets (2018-2023) & (Tons)
Figure 15. Methimazole API Consumed in Cream
Figure 16. Global Methimazole API Market: Cream (2018-2023) & (Tons)
Figure 17. Methimazole API Consumed in Enteric-coated Tablets
Figure 18. Global Methimazole API Market: Enteric-coated Tablets (2018-2023) & (Tons)
Figure 19. Global Methimazole API Sales Market Share by Application (2022)
Figure 20. Global Methimazole API Revenue Market Share by Application in 2022
Figure 21. Methimazole API Sales Market by Company in 2022 (Tons)
Figure 22. Global Methimazole API Sales Market Share by Company in 2022
Figure 23. Methimazole API Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Methimazole API Revenue Market Share by Company in 2022
Figure 25. Global Methimazole API Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Methimazole API Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Methimazole API Sales 2018-2023 (Tons)
Figure 28. Americas Methimazole API Revenue 2018-2023 ($ Millions)
Figure 29. APAC Methimazole API Sales 2018-2023 (Tons)
Figure 30. APAC Methimazole API Revenue 2018-2023 ($ Millions)
Figure 31. Europe Methimazole API Sales 2018-2023 (Tons)
Figure 32. Europe Methimazole API Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Methimazole API Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Methimazole API Revenue 2018-2023 ($ Millions)
Figure 35. Americas Methimazole API Sales Market Share by Country in 2022
Figure 36. Americas Methimazole API Revenue Market Share by Country in 2022
Figure 37. Americas Methimazole API Sales Market Share by Type (2018-2023)
Figure 38. Americas Methimazole API Sales Market Share by Application (2018-2023)
Figure 39. United States Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Methimazole API Sales Market Share by Region in 2022
Figure 44. APAC Methimazole API Revenue Market Share by Regions in 2022
Figure 45. APAC Methimazole API Sales Market Share by Type (2018-2023)
Figure 46. APAC Methimazole API Sales Market Share by Application (2018-2023)
Figure 47. China Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Methimazole API Sales Market Share by Country in 2022
Figure 55. Europe Methimazole API Revenue Market Share by Country in 2022
Figure 56. Europe Methimazole API Sales Market Share by Type (2018-2023)
Figure 57. Europe Methimazole API Sales Market Share by Application (2018-2023)
Figure 58. Germany Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Methimazole API Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Methimazole API Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Methimazole API Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Methimazole API Sales Market Share by Application (2018-2023)
Figure 67. Egypt Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Methimazole API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Methimazole API in 2022
Figure 73. Manufacturing Process Analysis of Methimazole API
Figure 74. Industry Chain Structure of Methimazole API
Figure 75. Channels of Distribution
Figure 76. Global Methimazole API Sales Market Forecast by Region (2024-2029)
Figure 77. Global Methimazole API Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Methimazole API Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Methimazole API Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Methimazole API Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Methimazole API Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のメチマゾールAPI市場予測 2023年-2029年] (コード：LP23DC03016)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のメチマゾールAPI市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のPVT高純度炭化ケイ素粉末市場予測 2023年-2029年
  • 世界の医薬品用高純度窒素市場予測 2023年-2029年
  • 世界のアメリシウム-243市場予測 2023年-2029年
  • 世界のバーケリウム-249市場予測 2023年-2029年
  • 世界のラジウム-224市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆